Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 23, 2019
Patent Application Number
14680860
Date Filed
April 7, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides compositions and methods for treating diseases associated with expression of CD19, e.g., by administering a recombinant T cell comprising the CD19 CAR as described herein, in combination with a kinase inhibitor, e.g., a kinase inhibitor described herein. The invention also provides kits and compositions described herein.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
